CLRB
Cellectar Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.20
-0.03 ▼ -0.93%
🌙 3월 13일 5:21 PM ET (한국 3/14 06:21)
$3.19
-0.01 ▼ -0.31%
| Index | - | P/E | - | EPS (ttm) | -10.34 | Insider Own | 6.18% | Shs Outstand | 0.00B | Perf Week | 15.94% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 23.49% | Insider Trans | -0.08% | Shs Float | 0.00B | Perf Month | -3.32% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -1.89 | Inst Own | 14.49% | Short Float | 2.26% | Perf Quarter | -20.4% |
| Income | -0.02B | P/S | - | EPS this Y | 52.34% | Inst Trans | 6.71% | Short Ratio | 1.16 | Perf Half Y | -39.39% |
| Sales | 0.00B | P/B | 1.69 | EPS next 5Y | 50.54% | ROA | -107.74% | Short Interest | 0.09M | Perf YTD | 8.47% |
| Book/sh | 1.89 | P/C | 1.03 | EPS past 3/5Y | 60.46% 48.41% | ROE | -170.27% | 52W High | -84.46% ($20.59) | Perf Year | -64.4% |
| Cash/sh | 3.11 | P/FCF | - | Sales past 3/5Y | - | ROIC | -213.04% | 52W Low | 30.61% ($2.45) | Perf 3Y | -93.16% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 74.61% | Gross Margin | - | Volatility(W/M) | 11.9% 8.96% | Perf 5Y | -99.45% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.29 | Perf 10Y | -99.98% |
| Dividend Ex-Date | - | Quick Ratio | 2.96 | EPS Q/Q | 18.57% | Profit Margin | - | RSI (14) | 52.02 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.96 | Sales Q/Q | - | SMA20 | 2.42% ($3.12) | Beta | 0.31 | Target Price | $12 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 3000000 | SMA50 | -2.28% ($3.27) | Rel Volume | 0.62 | Prev Close | $3.23 |
| Employees | 11 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | 153.07% - | SMA200 | -31.98% ($4.7) | Avg Volume(3M) | 0.08M | Price | $3.2 |
| IPO | 2005/6/14 | Option/Short | No/Yes | Trades | 435 | Volume | 47,710 | Change | -0.93% |
뉴스 로딩 중...